You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 2021433433138
Jun 202120420447
Jul 202112512541
Aug 2021919121
Sep 2021787827
Oct 2021868645
Nov 2021706927
Dec 2021676712
Jan 2022637242
Feb 2022414238
Mar 2022585941
Apr 2022434421
May 2022535531
Jun 2022485115
Jul 2022515117
Aug 2022474729
Sep 2022515135
Oct 2022465030
Nov 2022505224
Dec 2022383915
Jan 2023444411
Feb 2023676721
Mar 2023566032
Apr 2023232320
May 2023575833
Jun 2023424224
Jul 2023313217
Aug 2023181816
Sep 2023252612
Oct 2023364017
Nov 202326269
Dec 2023313321
Jan 2024545619
Feb 2024434329
Mar 2024495037
Total234523841014